GT BIOPHARMA, INC. Increase (Decrease) in Inventories
GT BIOPHARMA, INC. (GTBP) reported Increase (Decrease) in Inventories of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2018-03-01
- GT BIOPHARMA, INC. increase (decrease) in inventories for the quarter ending 2012-12-31 was -$59.00K.
- GT BIOPHARMA, INC. increase (decrease) in inventories for the quarter ending 2012-09-30 was $92.00K.
- GT BIOPHARMA, INC. increase (decrease) in inventories for the quarter ending 2011-12-31 was -$12.00K.
- GT BIOPHARMA, INC. increase (decrease) in inventories for the quarter ending 2011-09-30 was $0.00.
- GT BIOPHARMA, INC. increase (decrease) in inventories for fiscal 2017 was $0.00.
- GT BIOPHARMA, INC. increase (decrease) in inventories for fiscal 2016 was $0.00.
- GT BIOPHARMA, INC. increase (decrease) in inventories for fiscal 2015 was $0.00.
- GT BIOPHARMA, INC. increase (decrease) in inventories for fiscal 2014 was -$42.00K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-01 | ||||
| 2016-12-31 | $0.00 10-K · filed 2018-03-01 | ||||
| 2015-12-31 | $0.00 10-K/A · filed 2018-02-28 | ||||
| 2014-12-31 | -$42.00K 10-K/A · filed 2018-02-28 | ||||
| 2013-12-31 | -$17.00K 10-K · filed 2015-03-31 | $17.00K 10-K · filed 2015-01-08 | |||
| 2012-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08 | $33.00K derived: sum of 2 quarters · filed 2015-01-08 | -$47.00K 10-K · filed 2015-01-08 | ||
| 2012-09-30 | $92.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-21 | $12.00K 10-Q · filed 2012-11-21 | |||
| 2012-06-30 | -$80.00K 10-Q/A · filed 2012-09-13 | ||||
| 2011-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18 | -$12.00K derived: sum of 2 quarters · filed 2014-11-18 | -$12.00K 10-K · filed 2014-11-18 | ||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-21 | $0.00 10-Q · filed 2012-11-21 | |||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |